옵션 체인은 다양한 행사가격과 만기일에 대한 Coty의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Coty에 대한 시장 심리를 평가합니다..

Coty (NYSE:COTY) 주식, 옵션 체인

Coty

Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrities Kim Kardashian and Kylie Jenner to launch makeup products bearing their names. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.

Earnings

News

After-Hours Center

Movers

COTY

코티(NYSE:COTY)는 화요일 시장 마감 후 4분기 및 회계연도 실적을 발표했다. 보고서의 세부 내용은 다음과 같다. 주요 내용: 코티는 주당 3센트의 분기 손실을 보고했는데, 이는 분석가들의 합의된 주당 4센트 이익 추정치를 하회했다. 분기별 매출은 13억 6천만 달러로 분석가들의 예상치인 13억 8천만 달러를 밑돌았다.

코티는 부진한 4분기와 2024년 실적에도 강력한 2025년 지침을 발표하여 주가 소폭 상승

Coty Inc

WIIM

Coty shares are trading lower after TD Cowen downgraded the stock from Buy to Hold.

TD Cowen analyst Oliver Chen downgrades Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) from Buy to Hold and announces $8.5 price target.

Downgrades

Price Target

Analyst Ratings

TD Cowen Downgrades Coty to Hold, Announces $8.5 Price Target

DA Davidson analyst Linda Bolton Weiser maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Buy and lowers the price target from $14.5 to $12.5.

DA Davidson Maintains Buy on Coty, Lowers Price Target to $12.5

Raymond James analyst Olivia Tong maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Outperform and lowers the price target from $13 to $11.

Raymond James Maintains Outperform on Coty, Lowers Price Target to $11

Editor&#8217;s note: This story has been updated to correct the name of the Bernstein analyst covering Ford. 
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587386a45064ed0001b4b61b/lauren-lieberman">Barclays analyst Lauren Lieberman</a> downgraded the rating for Coty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) from Equal-Weight to Underweight and lowered the price target from $8 to $7. Coty shares closed at $7.43 on Wednesday. <a href="https://www.benzinga.com/quote/COTY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Sean Milligan downgraded Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) from Hold to Underperform and cut the price target from $93 to $61. Enphase Energy shares closed at $74.81 on Wednesday. <a href="https://www.benzinga.com/quote/ENPH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Laura Champine downgraded the rating for Crocs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) from Buy to Hold and lowered the price target from $150 to $110. Crocs shares closed at $102.74 on Wednesday. <a href="https://www.benzinga.com/quote/CROX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Bernstein analyst Daniel Roeska downgraded Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) from Outperform to Market Perform and announced a price target of $11. Ford shares closed at $11.19 on Wednesday. <a href="https://www.benzinga.com/quote/F/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59009b5a0bd9910001e5f2aa/bradley-thomas">Keybanc analyst Bradley Thomas </a>downgraded the rating for Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) from Overweight to Sector Weight. Dollar Tree shares closed at $62.41 on Wednesday. <a href="https://www.benzinga.com/quote/DLTR/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying Ford stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76-1024x586.png" alt="" class="wp-image-635158" style="width:545px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41776764/jim-cramer-this-financial-stock-is-a-buy-likes-broadcom">Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

CROX

DLTR

ENPH

This Ford Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday (CORRECTED)

Throughout the last three months, 18 analysts have evaluated Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $11.75, a high estimate of $17.00, and a low estimate of $7.00. Experiencing a 6.0% decline, the current average is now lower than the previous average price target of $12.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1731009651_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Coty by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$7.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ashley Helgans</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$8.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$14.50</td>
<td>$17.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$10.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Olivia Tong</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$10.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$10.00</td>
<td>$10.50</td>
</tr>
<tr>
<td>Ashley Helgans</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$10.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$17.00</td>
<td>$16.50</td>
</tr>
<tr>
<td>Robert Ottenstein</td>
<td>Evercore ISI Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Coty. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Coty compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Coty's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Coty's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/COTY/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coty analyst ratings.</a>
<h2>About Coty</h2>
Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrities Kim Kardashian and Kylie Jenner to launch makeup products bearing their names. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.
<h3>Coty's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Over the 3 months period, Coty showcased positive performance, achieving a revenue growth rate of 0.87% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Coty's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -7.35% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Coty's ROE stands out, surpassing industry averages. With an impressive ROE of -2.56%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Coty's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.82%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.08, caution is advised due to increased financial risk.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Peeling Back The Layers: Exploring Coty Through Analyst Insights

Barclays analyst Lauren Lieberman downgrades Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) from Equal-Weight to Underweight and lowers the price target from $8 to $7.

Barclays Downgrades Coty to Underweight, Lowers Price Target to $7

Outlook
Over the last several months, the beauty market has maintained solid momentum, though growth has moderated from the outsized double-digit growth of the last few years. Prestige fragrances remain an outperforming category, though growth has moderated by a couple of points exiting Q1. Mass beauty is now growing in the low single digits, with flattish performance in the mass cosmetics category. Within this backdrop, slower end demand and significant channel shifts in U.S. mass beauty and in Asia, are continuing to weigh on order levels into Q2, with sell-in tracking well below sell-out. As a result of these factors, Coty expect LFL sales growth in the first half of 3-4%.
The pace of category growth and consumer demand during the critical holiday period remains the central factor influencing the outlook for the second half, including retailer inventory levels and pace of re-orders. At present, Coty anticipates LFL growth in the second half to be relatively consistent with the first half, reflecting easier prior year comparisons and solid prestige fragrance performance on the one hand, and continued pressure in the Chinese mainland, Asia Travel Retail and U.S. mass cosmetics on the other hand.
In this very dynamic beauty market environment, Coty is future proofing its organization and processes to better capture new opportunities, respond to changes in the market with more agility, and solidify Coty's position as a beauty leader over the long term. Many of the workstreams are already under way, with an acceleration now in the timing of delivery, while others are newly initiated. Through the combination of these efforts, Coty now anticipates FY25 savings of over $120 million, an increase of over $45 million versus its initial target. And importantly, these projects should continue to deliver savings in FY26 and beyond.
Through the combination of continued sales growth, continuous gross margin expansion and increased cost savings for FY25 and beyond, while maintaining A&amp;CP in the high 20s percentage, Coty expects FY25 adjusted EBITDA to grow near the lower end of its prior guidance of +9-11% YoY. This outlook includes resumed adjusted EBITDA growth in Q2 in the mid single digit percentage, with steady EBITDA growth acceleration in Q3 and Q4. This adjusted EBITDA growth target, in conjunction with continued though more moderate revenue growth, reflects an even stronger adjusted EBITDA margin expansion in FY25 of close to 100 bps, following the 30 bps adjusted EBITDA margin expansion in FY24. Coty expects FY25 adjusted EPS at the low end of its prior guidance range of $0.54-0.57, reflecting mid teens percentage growth.
Finally, Coty continues to expect FY25 free cash flow to grow by a double-digit percentage YoY to the low to mid $400M range. With the tight inventory management by retailers adding some variability on cash inflow timing, Coty remains on track to exit CY24 with leverage below 3x and continues to target leverage close to 2.5x exiting CY24.

Guidance

Coty Expects FY25 Adjusted EPS At The Low End Of Its Prior Guidance Range Of $0.54-$0.57 Vs $0.55 Est.

Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.19 by 21.05 percent. This is a 66.67 percent increase over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $1.67 billion which missed the analyst consensus estimate of $1.68 billion by 0.51 percent. This is a 1.83 percent increase over sales of $1.64 billion the same period last year.

Earnings Misses

Coty Q1 Adj $0.15 Misses $0.19 Estimate, Sales $1.67B Miss $1.68B Estimate

Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) will release its quarterly earnings report on Wednesday, 2024-11-06. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Coty to report an earnings per share (EPS) of $0.19.
The announcement from Coty is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
The company's EPS missed by $0.07 in the last quarter, leading to a 6.3% increase in the share price on the following day.
Here's a look at Coty's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.04</td>
<td>0.06</td>
<td>0.20</td>
<td>0.17</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.03</td>
<td>0.05</td>
<td>0.25</td>
<td>0.09</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.0%</td>
<td>-3.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730822575_0.png" alt="eps graph" />
<h3>Tracking Coty's Stock Performance</h3>
Shares of Coty were trading at $7.47 as of November 04. Over the last 52-week period, shares are down 25.42%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analysts' Take on Coty</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Coty.
Analysts have given Coty a total of 17 ratings, with the consensus rating being Buy. The average one-year price target is $12.03, indicating a potential 61.04% upside.
<h3>Comparing Ratings with Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of e.l.f. Beauty, Interparfums and Edgewell Personal Care, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>As per analysts' assessments, e.l.f. Beauty is favoring an Buy trajectory, with an average 1-year price target of $197.5, suggesting a potential 2543.91% upside.</li>
<li>Interparfums is maintaining an Buy status according to analysts, with an average 1-year price target of $170.83, indicating a potential 2186.88% upside.</li>
<li>For Edgewell Personal Care, analysts project an Neutral trajectory, with an average 1-year price target of $39.25, indicating a potential 425.44% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for e.l.f. Beauty, Interparfums and Edgewell Personal Care, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Coty</td>
<td>Buy</td>
<td>0.87%</td>
<td>$875.40M</td>
<td>-2.56%</td>
</tr>
<tr>
<td>e.l.f. Beauty</td>
<td>Buy</td>
<td>49.99%</td>
<td>$231.28M</td>
<td>7.07%</td>
</tr>
<tr>
<td>Interparfums</td>
<td>Buy</td>
<td>10.67%</td>
<td>$220.76M</td>
<td>5.17%</td>
</tr>
<tr>
<td>Edgewell Personal Care</td>
<td>Neutral</td>
<td>-0.34%</td>
<td>$287.10M</td>
<td>3.13%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Coty ranks at the bottom for Revenue Growth, with the lowest percentage among peers. It also has the lowest Gross Profit among the group. In terms of Return on Equity, Coty is at the bottom as well. Overall, Coty lags behind its peers in key financial metrics.
<h3>Unveiling the Story Behind Coty</h3>
Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrities Kim Kardashian and Kylie Jenner to launch makeup products bearing their names. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.
<h3>Key Indicators: Coty's Financial Health</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Coty displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 0.87%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Coty's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -7.35% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Coty's ROE excels beyond industry benchmarks, reaching -2.56%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Coty's ROA excels beyond industry benchmarks, reaching -0.82%. This signifies efficient management of assets and strong financial health.
Debt Management: Coty's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.08, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<a href="https://www.benzinga.com/quote/COTY/earnings">To track all earnings releases for Coty visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of Coty's Earnings

<a href="https://www.loreal-finance.com/eng/news-release/sales-30-september-2024" title="https://www.loreal-finance.com/eng/news-release/sales-30-september-2024">https://www.loreal-finance.com/eng/news-release/sales-30-september-2024</a>

Macro Economic Events

Global

Economics

ULTA

L'Oreal Says Chinese Ecosystem Has Become Even More Challenging

L'Oréal Reports Q3 Net Sales Of €10.28B Vs €10.52B Est.; Organic Sales Growth At 3.4% Vs 6.0% Est.

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Coty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>)</h3>
<ul>
<li>On Oct. 14, Coty announced preliminary first quarter results and reiterated FY25 adjusted Ebitda outlook for +9-11% year over year growth. The company's stock fell around 11% over the past five days and has a <a href="https://www.benzinga.com/quote/coty">52-week low of $7.95</a>.</li>
<li>RSI Value: 29.19</li>
<li>COTY Price Action: Shares of Coty fell 2.3% to close at $7.99 on Wednesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101724&amp;t=be2bearmibe3na1"> latest COTY news. </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="897" height="853" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071526/image-136.png" alt="" class="wp-image-600324" style="width:719px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071526/image-136.png 897w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071526/image-136-300x285.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071526/image-136-768x730.png 768w" sizes="(max-width: 897px) 100vw, 897px" /></a></figure>
<h3 class="wp-block-heading">22nd Century Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Sept. 13, 22nd Century Group's chairman and CEO Lawrence Firestone purchased 39,000 shares at an average price of 27 cents per share, disclosed in an SEC filing. The company's stock fell around 43% over the past five days. It <a href="https://www.benzinga.com/quote/XXII">has a 52-week low</a> of $0.10.</li>
<li>RSI Value: 22.29</li>
<li>XXII Price Action: Shares of 22nd Century Group fell 17.4% to close at $0.11 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101724&amp;t=be2bearmibe3na1"> trend in XXII stock.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="917" height="833" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071557/image-137.png" alt="" class="wp-image-600325" style="width:679px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071557/image-137.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071557/image-137-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071557/image-137-768x698.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<h3 class="wp-block-heading">Mangoceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGRX#NASDAQ">MGRX</a>)</h3>
<ul>
<li>On Oct 14, Mangoceuticals announced a 1-for-15 reverse stock split.. The company's shares fell around 21% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/MGRX">low of $2.14</a>.</li>
<li>RSI Value: 29.63</li>
<li>MGRX Price Action: Shares of Mangoceuticals fell 6.8% to close at $2.47 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential b<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101724&amp;t=be2bearmibe3na1">reakout in MGRX shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="895" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071622/image-138.png" alt="" class="wp-image-600328" style="width:722px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071622/image-138.png 895w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071622/image-138-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/17071622/image-138-768x723.png 768w" sizes="(max-width: 895px) 100vw, 895px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41366043/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

Long Ideas

MGRX

XXII

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter

Jefferies analyst Ashley Helgans maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Buy and lowers the price target from $12 to $11.

Jefferies Maintains Buy on Coty, Lowers Price Target to $11

Barclays analyst Lauren Lieberman maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Equal-Weight and lowers the price target from $10 to $8.

Barclays Maintains Equal-Weight on Coty, Lowers Price Target to $8

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Jefferies raised WEX Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEX#NYSE">WEX</a>) price target from $190 to $210. Jefferies analyst Trevor Williams maintained a Hold rating. WEX shares closed at $213.76 on Tuesday. <a href="https://www.benzinga.com/quote/WEX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup boosted the price target for The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) from $115 to $140. Citigroup analyst Ygal Arounian maintained a Buy rating. Trade Desk shares closed at $117.68 on Tuesday. <a href="https://www.benzinga.com/quote/TTD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs raised the price target for Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) from $38 to $41. Goldman Sachs analyst Lizzie Dove maintained a Buy rating. Aramark shares closed at $39.01 on Tuesday. <a href="https://www.benzinga.com/quote/ARMK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen raised McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) price target from $280 to $300. TD Cowen analyst Andrew Charles maintained a HOLD rating. McDonald&#8217;s shares closed at $313.34 on Tuesday. <a href="https://www.benzinga.com/quote/MCD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>DA Davidson cut Coty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) price target from $17 to $14.5. DA Davidson analyst Linda Bolton Weiser maintained a Buy rating. Coty shares closed at $8.18 on Tuesday. <a href="https://www.benzinga.com/quote/COTY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) price target from $472 to $520. JP Morgan analyst Kian Abouhossein maintained an Overweight rating. Goldman Sachs shares closed at $522.38 on Tuesday. <a href="https://www.benzinga.com/quote/GS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS cut the price target for UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) from $680 to $650. UBS analyst Kevin Caliendo maintained a Buy rating. UnitedHealth settled at $556.29 on Tuesday. <a href="https://www.benzinga.com/quote/UNH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Susquehanna raised Las Vegas Sands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) price target from $51 to $59. Susquehanna analyst Joseph Stauff maintained a Positive rating. Las Vegas Sands shares closed at $50.95 on Tuesday. <a href="https://www.benzinga.com/quote/LVS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group increased the price target for Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) from $63 to $64. Evercore ISI Group analyst Glenn Schorr maintained an In-Line rating. Citigroup shares closed at $62.64 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how </a><a href="https://www.benzinga.com/quote/C/analyst-ratings">other </a><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">analysts view this stock</a>.</li>
<li>Oppenheimer raised Bank of America Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) price target from $49 to $50. Oppenheimer analyst Chris Kotowski maintained an Outperform rating. Bank of America shares closed at $42.14 on Tuesday. <a href="https://www.benzinga.com/quote/BAC/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying BAC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="512" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16152248/image-133-1024x512.png" alt="" class="wp-image-599167" style="width:628px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16152248/image-133-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16152248/image-133-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16152248/image-133-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/16152248/image-133.png 1341w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41358280/united-airlines-posts-upbeat-earnings-joins-morgan-stanley-u-s-bancorp-and-other-big-stocks-moving-h">United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday</a></li>
</ul>

ARMK

Bank of America To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday

DA Davidson analyst Linda Bolton Weiser maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Buy and lowers the price target from $17 to $14.5.

DA Davidson Maintains Buy on Coty, Lowers Price Target to $14.5

JP Morgan analyst Andrea Teixeira maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Neutral and lowers the price target from $11 to $10.

JP Morgan Maintains Neutral on Coty, Lowers Price Target to $10

Raymond James analyst Olivia Tong maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Outperform and lowers the price target from $14 to $13.

Raymond James Maintains Outperform on Coty, Lowers Price Target to $13

Canaccord Genuity analyst Susan Anderson maintains Coty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) with a Buy and maintains $14 price target.

Canaccord Genuity Maintains Buy on Coty, Maintains $14 Price Target

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street's best analysts during...

Buy/Sell: Wall Street's top 10 stock calls this week

Coty Inc ( ($COTY) ) has released its Q1 earnings. Here is a breakdown of the information Coty Inc presented to its investors. Coty Inc. is a globa...

Coty Inc. Shows Resilient Q1 Growth Amid Market Challenges

Morgan Stanley analyst Dara Mohsenian has maintained their neutral stance on COTY stock, giving a Hold rating yesterday. Dara Mohsenian's rating is...

Coty's Hold Rating: Balancing Solid Execution with Uncertain Market Conditions Amid Lowered EBITDA Guidance

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Nov. 4-8, 2024.

Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 9

Morgan Stanley lowered the firm's price target on Coty (COTY) to $9 from $12 and keeps an Equal Weight rating on the shares. The firm said on Frida...

Coty price target lowered to $9 from $12 at Morgan Stanley

Coty: With The Makeover Now Complete, This Prospect Is A Beauty

In a report released today, Linda Bolton Weiser from D.A. Davidson maintained a Buy rating on Coty (COTY – Research Report), with a price target of...

Coty (COTY) Gets a Buy from D.A. Davidson

DA Davidson lowered the firm's price target on Coty (COTY) to $12.50 from $14.50 but keeps a Buy rating on the shares after its Q1 earnings miss. T...

Coty price target lowered to $12.50 from $14.50 at DA Davidson

TD Cowen downgraded Coty (COTY) to Hold from Buy with a price target of $8.50, down from $11. While Coty has a unique business and platform with op...

Coty downgraded to Hold at TD Cowen on moderating growth, risk factors

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Coty (NYSE:<a href="https://investorplace.com/stock-quotes/coty-stock-quote/">COTY</a>) just reported results for the fourth quarter of 2024.<ul><li>Coty reported earnings per share of -3 cents. This was below the analyst estimate for EPS of 4 cents.</li><li>The company reported revenue of $1.36 billion.</li><li>This was worse than the analyst estimate for revenue of $1.38 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	
	The post <a href="https://investorplace.com/earning-results/2024/08/coty-stock-earnings-coty-for-q4-of-2024/">COTY Stock Earnings: Coty Misses EPS, Misses Revenue for Q4 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

COTY Stock Earnings: Coty Misses EPS, Misses Revenue for Q4 2024

BRBR

EBAY

FIVE

IPAR

KVUE

LMND

PTON

RBLX

SNOW

Press Releases

Sally Hansen® and Warner Bros. Team Up for a Scary Good Nail Polish Collection to Celebrate the Release of This Fall's Highly Anticipated Movie "Beetlejuice Beetlejuice"

Coty Reports Double-Digit Growth in FY24, Outpacing Beauty Market

Orveda, the French multi-award-winning biotech skincare brand, unveils LA MAISON ORVEDA NEW YORK CITY, a wellness sanctuary dedicated to glow and skin longevity, located in the heart of the Upper East Side.

Coty Launches Scientific Advisory Board on Skincare Innovation

Coty, A Fragrance Disruptor Since 1904

Coty Announces Preliminary First Quarter Results and Reiterates FY25 Adjusted EBITDA Outlook for +9-11% YoY Growth, Supporting Stronger EBITDA Margin Expansion

Coty Achieves Key Milestones and Sets New Targets in FY24 Sustainability Report

Coty Reports Solid Q1 Growth Fueled by Prestige Fragrances, Outperforming Beauty Market

Coty Inc. Announces Cash Tender Offer for Up to $250 Million Outstanding 5.000% Senior Secured Notes due 2026

Coty Inc. Announces Early Results of its Cash Tender Offer for a Portion of its Outstanding 5.000% Senior Secured Notes due 2026

PARIS:COTY

BellRing Brands

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Honest Co

Interparfums

Kenvue

Lifevantage

Medifast

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Enter

Safety Shot

The Beauty Health Company - Class A Common Stock

Beauty Health

Unilever

Usana Health Sciences

Veru

Waldencast

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Comments

Coty

Coty (COTY) 옵션

Coty (NYSE:COTY) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌